Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Aggrey Omu, Anzala"'
Autor:
Elizabeth Mueni Mutisya, Vincent Muturi-Kioi, Andrew Abaasa, Delvin Nyasani, Rhoda W. Kabuti, Laura Lunani, Timothy Kotikot, Moses Mundia, Gaudensia Mutua, Geoffrey Ombati, Hannah Nduta, Matt A. Price, Joshua Kimani, Aggrey Omu Anzala
Publikováno v:
BMC Public Health, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Objective To assess the feasibility of conducting HIV prevention trials among key populations in Nairobi, Kenya. Background HIV prevention trials require the inclusion of those at high risk of HIV infection and their informed decision to tak
Externí odkaz:
https://doaj.org/article/e0cd025d897d48ef8a1e53dee3e3ca2d
Autor:
Elizabeth Mueni Mutisya, Gaudensia Mutua, Delvin Nyasani, Hannah Nduta, Rhoda W Kabuti, Vincent Muturi-Kioi, Gloria Omosa-Manyonyi, Andrew Abaasa, Krysia Lindan, Matt A Price, Joshua Kimani, Aggrey Omu Anzala
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0238028 (2020)
ObjectiveTo evaluate factors associated with willingness to participate in future HIV vaccine trials among men who have sex with men and female sex workers living in Nairobi, Kenya.BackgroundWorking with 'key populations', those at elevated risk of H
Externí odkaz:
https://doaj.org/article/f322ed873ca04ac78513ae947b2a61f7
Autor:
Delvin Kwamboka Nyasani, Gaudensia Nzembi Mutua, Rose Miroyo Sajabi, Jane Wairimu Ng'ang'a, John Ndungu Gachie, Amos Macharia Maina, Laura Lunani Lusike, Aggrey Omu Anzala, Matthew A Price, Gloria Omosa Manyonyi
Publikováno v:
PLoS ONE, Vol 13, Iss 11, p e0206656 (2018)
OBJECTIVE:To evaluate initial reported willingness to participate in a hypothetical HIV vaccine clinical trial and actual participation of volunteers in a longitudinal observational study. METHODS:We recruited HIV negative male and female volunteers
Externí odkaz:
https://doaj.org/article/681042f6ed5248c1a9d1e34e0bb883e0
Autor:
Elizabeth Mueni, Mutisya, Vincent, Muturi-Kioi, Andrew, Abaasa, Delvin, Nyasani, Rhoda W, Kabuti, Laura, Lunani, Timothy, Kotikot, Moses, Mundia, Gaudensia, Mutua, Geoffrey, Ombati, Hannah, Nduta, Matt A, Price, Joshua, Kimani, Aggrey Omu, Anzala
Objective To assess the feasibility of conducting HIV prevention trials among key populations in Nairobi, Kenya. Background HIV prevention trials require the inclusion of those at high risk of HIV infection and their informed decision to take part an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c21fd071386d59e08fc1be0475f115a
https://doi.org/10.21203/rs.3.rs-1759819/v1
https://doi.org/10.21203/rs.3.rs-1759819/v1
Autor:
Aida, Sivro, Alexandra, Schuetz, Daniel, Sheward, Vineet, Joag, Sergey, Yegorov, Lenine J, Liebenberg, Nonhlanhla, Yende-Zuma, Andrew, Stalker, Ruth S, Mwatelah, Philippe, Selhorst, Nigel, Garrett, Natasha, Samsunder, Anisha, Balgobin, Fatima, Nawaz, Claudia, Cicala, James, Arthos, Anthony S, Fauci, Aggrey Omu, Anzala, Joshua, Kimani, Bernard S, Bagaya, Noah, Kiwanuka, Carolyn, Williamson, Rupert, Kaul, Jo-Ann S, Passmore, Nittaya, Phanuphak, Jintanat, Ananworanich, Aftab, Ansari, Quarraisha, Abdool Karim, Salim S, Abdool Karim, Lyle R, McKinnon
Publikováno v:
Science translational medicine. 10(425)
The gastrointestinal (GI) mucosa is central to HIV pathogenesis, and the integrin α(4)β(7) promotes the homing of immune cells to this site. Data from SIV animal models suggest that α(4)β(7) blockade provides prophylactic and therapeutic benefits
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::327075ba5aaf62d493169b6a723695a0
https://pubmed.ncbi.nlm.nih.gov/29367348
https://pubmed.ncbi.nlm.nih.gov/29367348